| Hy Diep, | |
|
2400 Moorpark Ave, 300, San Jose, CA 95128-2631 | |
| (408) 975-2730 | |
| (408) 975-2745 |
| Full Name | Hy Diep |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 11 Years |
| Location | 2400 Moorpark Ave, San Jose, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053609834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY26861 (California) | Secondary |
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| County Of Santa Clara | 1254244973 | 732 |
News Archive
Naturally occurring arsenic in private wells threatens people in many U.S. states and parts of Canada, according to a package of a dozen scientific papers to be published next week. The studies, focused mainly on New England but applicable elsewhere, say private wells present continuing risks due to almost nonexistent regulation in most states, homeowner inaction and inadequate mitigation measures.
Patients with high blood pressure who take calcium channel blockers and diuretics have an increased risk for cardiovascular disease (CVD) death compared to patients who take beta-blockers plus diuretics, according to a study in the current issue of JAMA.
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and six months ended June 30, 2009.
A recent article in the Centers for Disease Control and Prevention (CDC)'s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 5 days ago
| Entity Name | County Of Santa Clara |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699885079 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000784 |
News Archive
Naturally occurring arsenic in private wells threatens people in many U.S. states and parts of Canada, according to a package of a dozen scientific papers to be published next week. The studies, focused mainly on New England but applicable elsewhere, say private wells present continuing risks due to almost nonexistent regulation in most states, homeowner inaction and inadequate mitigation measures.
Patients with high blood pressure who take calcium channel blockers and diuretics have an increased risk for cardiovascular disease (CVD) death compared to patients who take beta-blockers plus diuretics, according to a study in the current issue of JAMA.
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and six months ended June 30, 2009.
A recent article in the Centers for Disease Control and Prevention (CDC)'s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 5 days ago
| Entity Name | County Of Santa Clara |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932313582 PECOS PAC ID: 1254244973 Enrollment ID: O20040413001159 |
News Archive
Naturally occurring arsenic in private wells threatens people in many U.S. states and parts of Canada, according to a package of a dozen scientific papers to be published next week. The studies, focused mainly on New England but applicable elsewhere, say private wells present continuing risks due to almost nonexistent regulation in most states, homeowner inaction and inadequate mitigation measures.
Patients with high blood pressure who take calcium channel blockers and diuretics have an increased risk for cardiovascular disease (CVD) death compared to patients who take beta-blockers plus diuretics, according to a study in the current issue of JAMA.
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and six months ended June 30, 2009.
A recent article in the Centers for Disease Control and Prevention (CDC)'s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hy Diep, 2400 Moorpark Ave, 300, San Jose, CA 95128-2631 Ph: () - | Hy Diep, 2400 Moorpark Ave, 300, San Jose, CA 95128-2631 Ph: (408) 975-2730 |
News Archive
Naturally occurring arsenic in private wells threatens people in many U.S. states and parts of Canada, according to a package of a dozen scientific papers to be published next week. The studies, focused mainly on New England but applicable elsewhere, say private wells present continuing risks due to almost nonexistent regulation in most states, homeowner inaction and inadequate mitigation measures.
Patients with high blood pressure who take calcium channel blockers and diuretics have an increased risk for cardiovascular disease (CVD) death compared to patients who take beta-blockers plus diuretics, according to a study in the current issue of JAMA.
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today reported financial results for the three and six months ended June 30, 2009.
A recent article in the Centers for Disease Control and Prevention (CDC)'s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.
› Verified 5 days ago
Dr. Rethel E. Gill, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1927 Otoole Way, San Jose, CA 95131 Phone: 707-861-8276 | |
Christina Wing In Gee, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2039 Forest Ave Ste 201, San Jose, CA 95128 Phone: 408-358-8090 | |
Marie Roman-clifton, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 751 S Bascom Ave, Psychology Services-pm&r, San Jose, CA 95128 Phone: 408-885-4445 | |
Dr. Jennifer Gregg, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Dept Of Psychology, One Washington Square, San Jose, CA 95192 Phone: 650-743-7230 | |
Mr. Donald B Dufford, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3880 S Bascom Ave, Suite 212, San Jose, CA 95124 Phone: 408-559-9088 Fax: 408-377-7833 | |
Dr. Sepideh Afrakhteh Katz, PH. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3500 Zanker Road, San Jose, CA 95134 Phone: 408-451-6198 | |
Dr. Kelly Sue Lynch, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 2001 The Alameda, Momentum For Mental Health Service Team Adult Outpatie, San Jose, CA 95126 Phone: 408-261-7777 Fax: 408-259-2273 |